Virpax Pharmaceuticals In... (VRPX)

0.20

-0.04 (-16.67%)

At close: Mar 03, 2025, 12:43 PM

Virpax Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-15.19M	-21.65M	-12.06M	-4.34M	-3.31M	-2.64M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	544.77K	745.03K	974.23K	1.47M	678.15K	384.95K
Other Working Capital	4.19M	4.05M	-2.71M	-13.09K	7.95K	-13.13K
Other Non-Cash Items	599.43K	745.03K	-61.82K	153.22K	564.64K	14.98K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	4.19M	3.06M	-3.4M	1.33M	931.89K	441.37K
Operating Cash Flow	-9.85M	-17.85M	-14.54M	-1.38M	-1.13M	-1.8M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	-1.5M	72.1K	500K	554.77K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	-5.19M	-50.88K	625K	n/a
Financial Cash Flow	n/a	n/a	51.33M	1.4M	1.13M	1.67M
Net Cash Flow	-9.85M	-17.85M	36.79M	13.26K	-6.83K	-124.87K
Free Cash Flow	-9.85M	-17.85M	-14.54M	-1.38M	-1.13M	-1.8M